ArticleBMC cancer2020

Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer.

Yoshinori Matsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.